XML 15 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash flows from operating activities:    
Net loss $ (4,800,554) $ (3,682,650)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation expense 6,692 13,055
Amortization of intangibles 26,768 22,705
Stock based compensation 697,635 307,331
Inventory Reserve 430,245 0
Employees paid in stock 217,262 748,171
Expense paid in stock 345,935 262,713
Non-cash operating lease expense (35,185) 3,808
Deferred profit and divesture-equity investment (See Note 6) 0 94,556
Gain on debt extinguishment-PPP 0 (276,180)
Changes in operating assets and liabilities:    
Decrease in accounts receivable 117,926 268,315
(Increase) in accounts receivable, related party (269,973) 0
(Increase) decrease in inventories (394,167) 940,788
(Increase) in advances on contracts (321,597) (979,615)
(Increase) in prepaid expenses and other current assets (147,578) (26,380)
Increase in accounts payable 604,976 99,713
Increase (decrease) in accounts payable, related party 377,801 (183,251)
(Decrease) increase in accrued expenses (464,800) 551,136
Decrease in accrued expenses, related party (191,789) (234,525)
Decrease operating right of use lease asset 39,338 0
Net cash used in operating activities (3,801,065) (2,070,310)
Cash flows from investing activities:    
Proceeds from furniture, fixtures, and equipment 85  
Purchase of furniture, fixtures, and equipment   (13,075)
Net cash provided by (used in) investing activities 85 (13,075)
Cash flows from financing activities:    
Proceeds from exercise of warrants 0 3,150,416
Payments finance lease obligations (4,234) (3,808)
Common stock issued to employee for option exercised 0 690,190
Net cash (used in) provided by financing activities (4,234) 3,836,798
Net (decrease) increase in cash and cash equivalents (3,805,214) 1,753,413
Cash and cash equivalents at beginning of period 14,764,346 14,223,917
Cash and cash equivalents at end of period $ 10,959,132 $ 15,977,330